These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 21106240
1. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia. Yao DM, Qian J, Lin J, Wang YL, Chen Q, Qian Z, Li Y, Wang CZ, Yang J. Leuk Res; 2011 Jul; 35(7):957-60. PubMed ID: 21106240 [Abstract] [Full Text] [Related]
2. Decreased expression of CCAAT/enhancer binding protein zeta (C/EBPzeta) in patients with different myeloid diseases. Qian J, Chen Z, Lin J, Wang W, Cen J. Leuk Res; 2005 Dec; 29(12):1435-41. PubMed ID: 16005964 [Abstract] [Full Text] [Related]
3. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features. Szankasi P, Ho AK, Bahler DW, Efimova O, Kelley TW. Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189 [Abstract] [Full Text] [Related]
4. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia. Jost E, do O N, Wilop S, Herman JG, Osieka R, Galm O. Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096 [Abstract] [Full Text] [Related]
6. Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia. Xu Z, Wang M, Wang L, Wang Y, Zhao X, Rao Q, Wang J. Leuk Res; 2009 Jul; 33(7):891-7. PubMed ID: 19250671 [Abstract] [Full Text] [Related]
8. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia. Galm O, Wilop S, Lüders C, Jost E, Gehbauer G, Herman JG, Osieka R. Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140 [Abstract] [Full Text] [Related]
9. C/EBPA gene mutation and C/EBPA promoter hypermethylation in acute myeloid leukemia with normal cytogenetics. Lu Y, Chen W, Chen W, Stein A, Weiss LM, Huang Q. Am J Hematol; 2010 Jun; 85(6):426-30. PubMed ID: 20513120 [Abstract] [Full Text] [Related]
10. Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts. Rethmeier A, Aggerholm A, Olesen LH, Juhl-Christensen C, Nyvold CG, Guldberg P, Hokland P. Br J Haematol; 2006 May; 133(3):276-83. PubMed ID: 16643429 [Abstract] [Full Text] [Related]
15. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia. Tao YF, Fang F, Hu SY, Lu J, Cao L, Zhao WL, Xiao PF, Li ZH, Wang NN, Xu LX, Du XJ, Sun LC, Li YH, Li YP, Xu YY, Ni J, Wang J, Feng X, Pan J. BMC Cancer; 2015 Oct 21; 15():756. PubMed ID: 26490736 [Abstract] [Full Text] [Related]
16. Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome. Lin J, Wang YL, Qian J, Yao DM, Zhu ZH, Qian Z, Xu WR. Leuk Res; 2010 Aug 21; 34(8):991-4. PubMed ID: 20116099 [Abstract] [Full Text] [Related]
18. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ. Hum Pathol; 2009 Nov 21; 40(11):1534-42. PubMed ID: 19695681 [Abstract] [Full Text] [Related]